Impact of an Adjuvant Chemotherapeutic Regimen on the Clinical Outcome in High Risk Patients with Upper Tract Urothelial Carcinoma: A Japanese Multi-Institution Experience-Reference-Cited by-同舟云学术

Impact of an Adjuvant Chemotherapeutic Regimen on the Clinical Outcome in High Risk Patients with Upper Tract Urothelial Carcinoma: A Japanese Multi-Institution Experience

Published:2015-04 Issue:4 Volume:193 Page:1122-1128
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Shirotake Suguru¹²³⁴⁵,Kikuchi Eiji¹²³⁴⁵,Tanaka Nobuyuki¹²³⁴⁵,Matsumoto Kazuhiro¹²³⁴⁵,Miyazaki Yasumasa¹²³⁴⁵,Kobayashi Hiroaki¹²³⁴⁵,Ide Hiroki¹²³⁴⁵,Obata Jun¹²³⁴⁵,Hoshino Katsura¹²³⁴⁵,Kaneko Gou¹²³⁴⁵,Hagiwara Masayuki¹²³⁴⁵,Kosaka Takeo¹²³⁴⁵,Kanao Kent¹²³⁴⁵,Kodaira Kiichiro¹²³⁴⁵,Hara Satoshi¹²³⁴⁵,Oyama Masafumi¹²³⁴⁵,Momma Tetsuo¹²³⁴⁵,Miyajima Akira¹²³⁴⁵,Nakagawa Ken¹²³⁴⁵,Hasegawa Shintaro¹²³⁴⁵,Nakajima Yosuke¹²³⁴⁵,Oya Mototsugu¹²³⁴⁵

Affiliation:

1. Department of Urology, Keio University School of Medicine (SS, EK, NT, KM, YM, HK, HI, JO, KH, GK, MH, TK, KK, AM, MO), Tokyo, Japan

2. Saiseikai Central Hospital (KM), Tokyo, Japan

3. Kyosai Tachikawa Hospital (HK), Tokyo, Japan

4. Kawasaki City Hospital (GK, SH), Tokyo, Japan

5. Musashino Yowakai Hospital (NT), Tokyo, Japan

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference29 articles.

1. European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update;Roupret;Eur Urol,2011